Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | SCNI Scinai Immunotherapeutics Ltd. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.42 +0.7% | $16.31 +6.3% |
| StockIQ Score | 46D+ Moderate Risk: Medium | 42D Weak Risk: Medium |
| Technical | 13F | 36F |
| Fundamental | 62C+ | 35F |
| Growth | 60C+ | 50C- |
| Fair Value | 38F | 38F |
| News | 80A- | 50C- |
| Quality | 55C | 50C- |
| Risk | 46D+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Scinai Immunotherapeutics (SCNI) outperforms Ascentage Pharma (AAPG) in most categories. SCNI has a stronger investor score (46 vs. 42) and a higher overall rating (MODERATE vs. WEAK). Its fundamental and growth scores are also higher (62 vs. 35, and 60 vs. 50), showing better underlying strength and expansion potential. Both share the same valuation score of 38, but SCNI’s technical score (13) is notably weaker than AAPG’s (36).
